Английская Википедия:Deuruxolitinib

Материал из Онлайн справочника
Перейти к навигацииПерейти к поиску

Шаблон:Short description Шаблон:Infobox drug

Deuruxolitinib (CTP-543) is a Janus kinase inhibitor selective for JAK1 and JAK2. It is in development to treat alopecia areata.[1] If approved the drug would compete with others with a similar mechanism of action developed by Eli Lilly and Pfizer.[2]

Deuruxolitinib is a deuterated derivative of ruxolitinib.

References

Шаблон:Reflist